For Investors

Press Releases

ReWalk Announces Regional Blue Cross Blue Shield Plan Beneficiaries Are Winning Requests to Walk Again

04/25/19

Independent reviewer authorizes coverage of ReWalk system for another paralyzed individual, the 17th by a regional BCBS plan MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, April 25, 2019 /PRNewswire/ -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that an

Read More
Read More

ReWalk Robotics to Present at the ThinkEquity Conference on May 2nd

04/23/19

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , April 23, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski , Chief Executive Officer and Andy Dolan , Vice President of Marketing, will present at the ThinkEquity Conference in

Read More
Read More

ReWalk Announces First Personal Exoskeleton Provided to Cigna Beneficiary

04/16/19

Reimbursement of the device marks a key milestone in the Company's relationship with major U.S. private insurers. MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , April 16, 2019 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), announced today that the first Cigna

Read More
Read More

ReWalk Robotics Announces Closing of Registered Direct Offering for $4.25 Million Priced At-the-Market

04/05/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 816,914 ordinary shares at a purchase price of $5.2025

Read More
Read More

ReWalk Robotics Announces Pricing of Registered Direct Offering for $4,250,000

04/03/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , April 03, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with institutional investors providing for the issuance of approximately 816,914 ordinary

Read More
Read More

ReWalk Robotics Completes One-for-Twenty-Five Reverse Share Split

03/29/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , March 29, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.  (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) reported today that it has completed the reverse share split of ReWalk ordinary share at a ratio of one-for-twenty-five shares, which will take

Read More
Read More

ReWalk Robotics Announces Closing of $4.37 Million Public Offering

02/25/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 25, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the closing and funding of its previously announced public offering of 19,000,000 ordinary shares at a price to the public of $0.23 per

Read More
Read More

ReWalk Robotics Announces Pricing of $4.37 Million Public Offering of Ordinary Shares

02/21/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 21, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced the pricing of a public offering of 19,000,000 ordinary shares, offered at a price to the public of $0.23 per share, for gross proceeds

Read More
Read More

ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares

02/20/19

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 20, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) today announced that it intends to offer and sell, subject to market and other conditions, its ordinary shares in a public offering. The offering is

Read More
Read More

ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation

02/19/19

Innovation in robotic rehabilitation technology will provide the first-of-its-kind medical device to rehab clinics nationwide, to treat the millions of patients with lower limb disability due to stroke MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , Feb.

Read More
Read More

ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices

02/13/19

Cigna Transitions to Case-by-Case Review Process, Eliminating Non-Coverage Policy MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 13, 2019 /PRNewswire/ --  ReWalk Robotics, Ltd.  (Nasdaq: RWLK) ("ReWalk" or the "Company"), disclosed today that Cigna Corporation , a leading global health service

Read More
Read More

ReWalk Robotics Reports Fourth Quarter 2018 Financial Results

02/08/19

— 2018 total revenue of $6.5 million and $1.6 million during the fourth quarter of 2018 — — Preparing for 2019 commercial launch of ReStore for stroke patients — YOKNEAM ILIT, Israel and MARLBOROUGH, Mass. , Feb. 08, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.

Read More
Read More
Displaying 133 - 144 of 281